Ketoacid supplementation partially improves metabolic parameters in patients on peritoneal dialysis

Peritoneal Dialysis International

Volumn 35, Issue 7, 2015, Pages 736-742

  Dong, Jie ^a,b,c,d   Li, Yan Jun ^a,b,c,d   Xu, Rong ^a,b,c,d   Ikizler, Talat Alp ^e   Wang, Hai Yan ^a,b,c,d  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Insulin resistance; Ketoacids; Metabolic; PD; Peritoneal dialysis

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN; OXOACID; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ENDOTHELIAL DYSFUNCTION; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITALIZATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE AGED; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; AGED; DIETARY SUPPLEMENT; KIDNEY FAILURE, CHRONIC; METABOLISM;

ADULT; AGED; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KETO ACIDS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES;

EID: 84951279357     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2014.00151     Document Type: Article

References (30)

1. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13:1894-900.
2. Li Y, Zhang L, Gu Y, Hao C, Zhu T. Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis. Perit Dial Int 2013; 33:411-8.
3. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS, et al. Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 2007; 12:391-8.
4. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981; 19:564-7.
5. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Impact of peritoneal absorption of glucose on appetite, protein catabolism and survival in CAPD patients. Clin Nephrol 1996; 45:194-8.
6. Zhe XW, Zeng J, Tian XK, Chen W, Gu Y, Cheng LT, et al. Pulse wave velocity is associated with metabolic syndrome components in CAPD patients. Am J Nephrol 2008; 28:641-6.
7. Chen HY, Kao TW, Huang JW, Chu TS, Wu KD. Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients. Blood Purif 2008; 26:138-44.
8. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008; 3:505-21.
9. Mak RH, Turner C, Thompson T, Haycock G, Chantler C. The effect of a low protein diet with amino acid/keto acid supplements on glucose metabolism in children with uremia. J Clin Endocrinol Metab 1986; 63:985-9.
10. Rigalleau V, Blanchetier V, Combe C, Guillot C, Deleris G, Aubertin J, et al. A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients. Am J Clin Nutr 1997; 65:1512-6.
11. Linn T, Santosa B, Gronemeyer D, Aygen S, Scholz N, Busch M, et al. Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia 2000; 43:1257-65.
12. Mak RH. Insulin, branched-chain amino acids, and growth failure in uremia. Pediatr Nephrol 1998; 12:637-42.
13. Layman DK. The role of leucine in weight loss diets and glucose homeostasis. J Nutr 2003; 133:S261-7.
14. Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007; 56:1647-54.
15. Torres-Leal FL, Fonseca-Alaniz MH, Teodoro GF, de Capitani MD, Vianna D, Pantaleao LC, et al. Leucine supplementation improves adiponectin and total cholesterol concentrations despite the lack of changes in adiposity or glucose homeostasis in rats previously exposed to a high-fat diet. Nutr Metab (Lond) 2011; 8:62.
16. Zemel MB, Bruckbauer A. Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects. Nutrients 2012; 4:529-41.
17. Ohno T, Tanaka Y, Sugauchi F, Orito E, Hasegawa I, Nukaya H, et al. Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis. Hepatol Res 2008; 38:683-8.
18. Teta D, Maillard M, Halabi G, Burnier M. The leptin/adiponectin ratio: potential implications for peritoneal dialysis. Kidney Int Suppl 2008:S112-8.
19. Axelsson J, Stenvinkel P. Role of fat mass and adipokines in chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17:25-31.
20. Dong J, Li Y, Xu Y, Xu R. Daily protein intake and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 2011; 26:3715-21.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9.
22. Gursu EM, Ozdemir A, Yalinbas B, Gursu RU, Canbakan M, Guven B, et al. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients. Clin Nephrol 2006; 66:263-8.
23. Lin SH, Lin YF, Kuo SW, Hsu YJ, Hung YJ. Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD. Am J Kidney Dis 2003; 42:774-80.
24. Li Y, Xie QH, You HZ, Tian J, Hao CM, Lin SY, et al. Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients-a randomized crossover trial. Perit Dial Int 2012; 32:507-15.
25. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, et al. Adiponectin and Adipor1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010; 464:1313-9.
26. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274:1185-8.
27. Hung AM, Sundell MB, Egbert P, Siew ED, Shintani A, Ellis CD, et al. A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clin J Am Soc Nephrol 2011; 6:767-74.
28. Park JT, Yoo TH, Kim JK, Oh HJ, Kim SJ, Yoo DE, et al. Leptin/adiponectin ratio is an independent predictor of mortality in nondiabetic peritoneal dialysis patients. Perit Dial Int 2013; 33:67-74.
29. Ryan AS, Ge S, Blumenthal JB, Serra MC, Prior SJ, Goldberg AP. Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J Am Geriatr Soc 2014; 62:607-14.
30. Davis NJ, Crandall JP, Gajavelli S, Berman JW, Tomuta N, Wylie-Rosett J, et al. Differential effects of low-carbohydrate and low-fat diets on inflammation and endothelial function in diabetes. J Diabetes Complications 2011; 25:371-6.